Gordon Mills, M.D., Ph.D., was fresh out of college when his first journal article appeared in 1976. He’s been quite busy since then, with a publication count that just hit quadruple digits.
Over the holiday break, the OHSU Knight Cancer Institute’s director of precision oncology received word of the acceptance of the 1,000th paper he has authored or co-authored.
“I had a wonderful Christmas present,” Mills says. Moving from MD Anderson Cancer Center to OHSU last year, he says, led to finishing projects and pushing papers out.
“In 2018, my team had 86 papers published or accepted with 51 of these in Nature, Cell or Science or their clones. Many of the papers this year are true team science papers related to pan cancer analysis of the Cancer Genome Atlas. Indeed, the vast majority of papers throughout my career have been collaborative papers with my team helping others with their efforts. This is a great testimony to the dedication and expertise of the team that I have had the privilege to work with.”
Mills and his co-authors have been cited 95,763 times, according to Scopus, the citation database. His h-index, a popular measure of scientific productivity, stands at 141, which is truly exceptional. For comparison, Nobel Prize-winner James Allison has an h-index of 111. Harold Varmus, the former NCI and NIH director has an h-index of 102. Knight Cancer Institute Director Brian Druker’s is 108.
Mills is a professor in the Department of Cell, Developmental and Cancer Biology in the OHSU School of Medicine and the Wayne and Julie Drinkward Chair in Precision Oncology.